Lindsey Trickett
Investor Relations Contact at F-STAR THERAPEUTICS, INC.
Profile
Lindsey Trickett is currently the Vice President of Investor Relations at Prelude Therapeutics, Inc. and the VP of Investor Relations & Communications at F-star Therapeutics, Inc. She previously worked as the Vice President of Investor Relations at Intellia Therapeutics, Inc. Ms. Trickett received an undergraduate degree from the University of Kentucky and an MBA from Georgetown University.
Lindsey Trickett active positions
| Companies | Position | Start |
|---|---|---|
| F-STAR THERAPEUTICS, INC. | Investor Relations Contact | - |
| PRELUDE THERAPEUTICS INCORPORATED | Investor Relations Contact | - |
Former positions of Lindsey Trickett
| Companies | Position | End |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Investor Relations Contact | - |
Training of Lindsey Trickett
| University of Kentucky | Undergraduate Degree |
| Georgetown University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| Private companies | 1 |
|---|---|
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company was founded on October 7, 2002 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Lindsey Trickett
